NCT02751905View on ClinicalTrials.gov

Absorption, Metabolism, and Excretion Study of BIIB074

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Neuropathic Pain

Interventions

DRUG

BIIB074

Administered orally as specified in treatment arm

Trial Locations (1)

53704

Research Site, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY